GlassScriptPhysician profile
Stephen B Clyne
NPI 1427026210
$1,821.12
in general payments reported to CMS, 2019-2025
19 companies · $515 in 2025
The $515 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $589 · 2021: $22.57 · 2022: $19.74 · 2023: $161 · 2024: $514 · 2025: $515.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,190.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,189.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $255.62 | 2019-2022 | |
| Axogen | $180.73 | 2023-2024 | Avance Nerve Graft, Axoguard Nerve Protector, Axoguard Nerve Cap |
| Genzyme Corporation | $172.33 | 2023-2025 | |
| Integra Lifesciences Corporation | $164.78 | 2024 | Relieva Spinplus Nav, Trudi Probe, Inspira Air |
| Optinose US, INC. | $158.48 | 2024-2025 | |
| Harrow Eye, LLC | $137.57 | 2025 | Vevye |
| Smith+Nephew, INC. | $128.16 | 2023-2025 | Stravix |
| Astrazeneca Pharmaceuticals LP | $124.98 | 2019 | |
| Medtronic USA, INC. | $110.00 | 2019 | |
| Aerin Medical INC. | $108.17 | 2019 | |
| Amgen INC. | $85.19 | 2024-2025 | Tezspire, Tepezza |
| Alcon Vision LLC | $46.04 | 2025 | Eysuvis, Tryptyr |
| Merck Sharp & Dohme LLC | $33.36 | 2025 | Keytruda |
| Kaleo, INC. | $23.78 | 2023 | Auvi-Q |
| Glaxosmithkline, LLC. | $23.37 | 2024 | Nucala |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $20.42 | 2025 | Xiidra, Miebo |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $19.11 | 2019 | |
| Medtronic, INC. | $15.32 | 2024 | Propel |
| Alk-Abello, INC | $13.71 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Clyne listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.